false
OasisLMS
Hamburger Menu
Catalog
Expert Perspective: Outcomes in Fetuses and Neonat ...
Expert Perspective: Outcomes in Fetuses and Neonates with Severe LQTS
Description
HRS member Jeremy P. Moore, MD, MS, FHRS, CCDS, CEPS-P, presents new data showing that fetuses and/or newborns with LQT3, but not those with LQT1 or LQT2, presenting with severe arrhythias are at high risk of frequent and lethal cardiac events. Genotyping is, therefore, useful for risk stratification among affected fetuses and newborns.
Summary
Availability:
On-Demand
Cost:
FREE
Credit Offered:
No Credit Offered
×
Expert Perspective: Outcomes in Fetuses and Neonates with Severe LQTS Course List
Recommended
Learning Activity Title
Learning Activity Title
Learning Activity Title
HRS Board Review Course 2025 and Self-Assessment Exam
Multiple Credits
$1,425.00 - $2,100.00
Learning Activity Title
Learning Activity Title
Learning Activity Title
HRS Board Review Course 2025
Multiple Credits
$1,150.00 - $1,650.00
Login
User Login
Continue with Google
OR
Email
Required
Password
Required
Logging In…
Forgot Password
×
Please select your language
1
English